Drug for treating phlegm turbidity nasopharynx cancer and preparation method thereof

Abstract

The invention discloses a drug for treating phlegm turbidity nasopharynx cancer and a preparation method thereof. The drug comprises the following raw medicinal materials: thunbery fritillary bulb, fructus trichosanthis, bamboo juice, platycodon grandiflorum, sea-buckthorn, seaweed, sea-tangle, air potato, concha meretricis seu cyclinae, amur foxtail, concha arcae, mint, burdock, rattletop, radix ranunculi ternate, rhodiola rosea, mother chrysanthemum, sea snail, calyx seu fructus physalis, lesser duckweed, rhizoma phragmitis, dayflower, fructus forsythia, herba andrographitis, radix isatidis, folium isatidis, belamcanda sinensis, oldenlandia diffusa and blackend swallowwort root. The drug disclosed by the invention has the beneficial effects that the drug is used for reducing phlegm and resolving masses, and resolving toxin and dispersing swelling as main functions by using the traditional Chinese medicine theory in China, and has the advantages of being good in effect, quick to take effect, high in safety and free of toxic and side effects on treatment of the phlegm turbidity nasopharynx cancer.

Description

[0001] technical field [0002] The present invention relates to a medical preparation containing raw materials derived from plants, animals or minerals, in particular to a medicine for treating nasopharyngeal carcinoma of phlegm-turbidity aggregation type and a preparation method thereof. [0003] Background technique [0004] Nasopharyngeal carcinoma is one of the most common malignant tumors in my country. It is more common in Guangdong, Guangxi, Hunan, Fujian, Jiangxi and other provinces in southern China. The incidence rate of men is 2 to 3 times that of women. The age distribution of cases in my country is 3 to 90 years old, but 30-50 years old is the high-incidence age area. [0005] The cause of nasopharyngeal carcinoma is unknown, but it is generally believed that it may be related to genetic factors, Epstein-Barr virus infection, environment and chemical carcinogenic factors. It often occurs in the pharyngeal recess and anterior wall of the nasopharynx. The lesion...

AI Technical Summary

Problems solved by technology

2. Surgical treatment is only suitable for: ①Primary cancer of the nasopharynx; ②Cervical lymph node metastases; ③Residual or recurrent lesions after radiotherapy

Moreover, for some patients with advanced nasopharyngeal carcinoma who have lost the opportunity of radiotherapy and chemotherapy, syndrome differentiation and treatment can also be used, which has a certain therapeutic effect and may allow patients to survive with tumors